Gaia Griguolo: PROs from EMBER3 Trial Presented at ASCO25

Gaia Griguolo, Junior Faculty Fixed-term Researcher at University of Padua, posted on X:

“PROs from EMBER3 trial presented at ASCO25 by Giuseppe Curigliano.

QoL and global health status generally maintained with imlunestrant e imlunestrant+abema. However, significant more diarrhea reported with imlunestrant+abema.”